• This study describes renal function at multiple points in time after transplantation and the influence of donor and recipient factors independent of rejection on this function. Donor and recipient records for 83 consecutive cadaveric renal transplants performed between 1992 and 1994 at Johns Hopkins Bayview Medical Center were reviewed retrospectively. Donor age, gender, weight, terminal serum creatinine (Cr), intensive care unit days, blood pressure, presence of cardiac arrest, kidney only versus multiple organ donation, and cold ischemia time and recipient age, gender, weight, pretransplant pregnancy status, and rejection episodes were recorded. The influences of each of these parameters on changes in recipient Cr clearance over time (derived using the CockcroftGault formula from recipient serum Cr at 3 months and annually up to 5 years) were analyzed first individually, then together in an analysis with multiple explanatory variables. Parameters indicative of donor ischemia (ie, donor blood pressure, pressor administration, and occurrence of cardiac arrest) were not predictive of the course of recipient Cr clearance. With the inclusion of rejection, this analysis shows the magnitude of the independent effects that donor age, donor Cr clearance, and recipient gender have on the subsequent time course of recipient Cr clearance (P < 0.05). Recipient gender and the presence of rejection appear to have a fixed effect on the level of Cr clearance, whereas donor age and donor Cr clearance appear to influence the level and the time course of recipient Cr clearance. Of all these factors, donor age appears to have the greatest impact on recipient Cr clearance at all times. Analyzing renal function in this way may prove to be a more sensitive indicator than actuarial survival analysis for evaluating the early effects of changes in transplantation protocols and pharmacologic interventions.
T
HE APPLICATION of actuarial analysis based on annual survival rates to clinical decision making in renal transplantation has two major limitations. First, because 1-year survival rates exceed 90%, 1 the impact of therapeutic advances may not be apparent without long-term follow-up based on these criteria. Second, these data represent the pooled consensus of different centers with different demographics and may not be applicable directly to individual programs. An approach to evaluation based on criteria other than patient and graft survival is needed.
A series of studies showed that donor and recipient nonimmunologic parameters influence short-term and long-term graft survival and that these factors correlate with renal function when measured at discrete points in time. Chertow et al 2 showed in a multivariate analysis of the UNOS database (October 1987 through December 1991) that after adjusting for immunologic factors (panel-reactive antibodies, transfusions, and HLA mismatch), the relative risk of graft failure is associated significantly with donor age, gender, and race and recipient body surface area. Terasaki et al, 3 also evaluating the UNOS registry for the years 1987 through 1994, corroborated this impact of nonimmunologic parameters on long-term graft survival. Their study showed that renal function at the time of discharge (reflected by serum creatinine [Cr] ) significantly affects 1-year graft survival and long-term halflife of the allograft. Discharge serum Cr in turn was influenced significantly by donor age, donor sex, mode of donor death, recipient size, and recipient cold ischemia time. Within the first year, this effect was independent of and additive to the effect of matching. Other investigations 4, 5 showed further the importance of HLA antigenindependent determinants on graft function by comparing outcome at various time intervals (6 months and 2 years) between paired recipients of allografts from the same donor with recipients of allografts from different donors. Cosio et al 4 attributed 64% of the variability in renal function, as manifested by serum Cr at 6 months, to donor factors. Donor age was important but could not account for the entire effect. Other donor factors could not be elucidated because of the study design.
In this study, we analyzed the course of renal function as a continuum over time after transplantation. Our data show that effects on recipient Cr clearance of nonimmunologic factors (ie, donor age, donor Cr clearance, and recipient gender) independent of the impact of rejection are strong enough to be shown within a single center. Displaying renal function longitudinally in this manner allows a better appraisal of the influence these parameters have on the magnitude and stability of renal function. This methodology serves as a foundation for the early appraisal of new donor selection and recipient protocols and therapeutic interventions.
MATERIALS AND METHODS
Donor and recipient records for 83 consecutive cadaveric renal transplants performed between 1992 and 1994 at Johns Hopkins Bayview Medical Center were reviewed retrospectively. Donor factors recorded included age, gender, weight, serum Cr just before declaration of death, number of intensive care unit days, blood pressure (systolic, diastolic, duration of lowest blood pressure), pressor administration, presence of cardiac arrest, whether the patient was a kidney-only or multiple organ donor, and cold ischemia time. Recipient factors recorded included age; gender; weight; pregnancy status before transplantation for women; rejection (single or multiple episodes); and serum Cr at 1 and 3 months and 1, 2, 3, 4, and 5 years. All rejection episodes were diagnosed by pathologic criteria. Cr clearance, as a measure of glomerular filtration rate (GFR), was estimated using the CockcroftGault formula. If allografts failed, Cr clearance was considered 0 at the next time point, then the patient was censored from further analysis. If patients died or were lost to followup, they were censored from analysis after the last available Cr clearance measurement.
Descriptive statistics are presented for donor and recipient factors. These statistics are evaluated further according to the gender of the recipient. For numerical variables, the means were compared by applying the two-sample t-test, whereas for categorical variables, the percent in each group were tested for equality by using a chi-square test.
To evaluate the course of Cr clearance as a continuous parameter after transplantation, a linear mixed-effects regression analysis with a quadratic time trend was used. [6] [7] [8] This statistical methodology differs from conventional multiple linear regression by allowing for the evaluation of the effects of multiple variables on changes in Cr clearance as measured repeatedly in the same individual over a prolonged time rather than on single Cr clearance per individual and accounts for variability among individuals. The effects of each donor and recipient factor on the course of Cr clearance through time initially were evaluated separately (univariate analysis). The parameters that by these analyses were found to have a significant impact on the level and the time course of recipient Cr clearance were included in an analysis with multiple explanatory variables. Factors losing statistical significance when analyzed together were eliminated. Data are displayed for individual factors found to be significant by the univariate analyses and for the final multiple variable statistical analysis. To derive graphs, variables are fixed at the median and first and third quartiles for donor weight and donor Cr clearance and for age groups corresponding with ideal and extended donor criteria.
RESULTS
The patients included in this study were recipients of 83 consecutive cadaveric renal transplants performed by a single surgeon (L.E.R.) at Johns Hopkins Bayview Medical Center between January 1, 1992, and December 31, 1994. Baseline maintenance immunosuppression consisted of prednisone, cyclosporine, and imuran during this time period. Donor and recipient characteristics are listed in Table 1 .
Univariate Analysis
Donor race, blood pressure, steroid and pressor administration (vasopressin, dopamine, and epinephrine), and occurrence of cardiac arrest; cold ischemia time; and recipient age, race, weight, and pretransplant pregnancy status did not influence significantly the level or time course of recipient Cr clearance. The mean Cr clearance of recipients from multiple organ donors was a constant 11.2 mL/min greater than that of recipients of allografts from kidney-only donors over the entire follow-up period (P ϭ 0.05). Recipient gender influenced the course of Cr clearance after transplantation. At any given time, the mean Cr clearance for female recipients was 14.1 mL/min less than that of male recipients (P ϭ 0.01). Donor gender tended to influence outcome, but its effect was not statistically significant (P ϭ 0.07). Recipients of allografts from female donors had a mean Cr clearance 10.0 mL/min less than that of recipients from male donors. This trend in donor/recipient gender mismatch was additive with female donors to male recipients having a mean Cr clearance 24.1 mL/ min less than male donors to female recipients.
This influence of recipient gender on the course of Cr clearance after transplantation could not be explained by any of the factors examined. Donor and recipient characteristics separated by recipient gender are listed in Table 2 . Male and female recipients did not differ with regard to donor characteristics and cold ischemia time. Male and female recipients were similar with regard to age, race, weight, and incidence of rejections.
For female recipients, pregnancy before transplantation did not influence the posttransplant course of Cr clearance (P ϭ 0.70).
Donor age significantly (P Ͻ 0.05) influenced the time course of recipient Cr clearance; this is depicted graphically in Fig 1. For purposes of display and comparison, results of the analysis are divided into four groups. Age cutoffs were selected to reflect young pediatric (Յ12 years), adolescent (12 to 20 years), ideal adult (20 to 55 years), and older adult donors (Ն55 years). Donor weight, donor-to-recipient weight ratio, and donor Cr clearance also influenced Cr clearance individually after transplantation (P Ͻ 0.05) as shown in Fig 2. When these analyses were confined to donors aged 20 to 55 years, significant influences of these parameters were lost.
After a first rejection episode, the mean Cr clearance fell 11.3 mL/min (P ϭ 0.01). Mean Cr clearance fell another 9.4 mL/min after a second rejection episode, but this effect was not quite statistically significant (P ϭ 0.09).
Analysis Using Multiple Explanatory Variables
Full data sets were available from 62 allograft recipients for inclusion in the final analysis. In this final analysis, only donor age, donor Cr clearance, recipient gender, and presence of a rejection episode retained significant independent influences on subsequent recipient Cr clearance (Table 3 ). This analysis showed that after a first rejection episode, a recipient's Cr clearance fell by 12.5 mL/min but, apart from this change in level, continued with the same pattern of change over subsequent time as if no rejection occurred. Figure 3 shows the correlation (r ϭ 0.96) between the Cr clearance values predicted from this analysis and the Cr clearance values observed for each patient. The high correlation shows that the factors included in this analysis account for most of the observed variability of Cr clearance over time after transplantation in this study.
The calculated courses of Cr clearance for rejection-free recipients separated into the four donor age groups as predicted by this analysis are shown in Fig 4. The curves are derived using mean donor Cr clearance and depicted by recipient gender. Cr clearance values for female recipients are shifted uniformly downward across time by 10.8 mL/min for all donor age groups.
This analysis further shows that the Cr clearance of recipients of kidneys from pediatric donors, although initially lower than for recipients of kidneys from the other age groups, increases steadily with time. By 18 months, renal function in this group appears as good as that of recipients of allografts from adolescent and young adult donors. The two older groups (20 to 55 years and Ͼ55 years) have Cr clearance values that are 21.9 and 39.5 mL/min lower than the 12 to 20 years age group.
DISCUSSION
Nonimmunologic factors related to the donor organ and to donor/recipient characteristics influence short-term and long-term renal allograft function and survival as shown by single center experience [4] [5] [9] [10] [11] [12] and analysis of the UNOS data registry. [1] [2] [3] 13 Studies such as these have defined less than ideal traits for allograft longevity, including mode of donor death; extremes of donor age; and donor and recipient gender, race, and size. Although many of these nonimmunologic parameters have been identified, the degree of influence of each factor on long-term allograft function independent of rejection has been difficult to assess. 4, 9, 11, 13 In this study, using a single-center experience of 83 consecutive cadaveric renal transplant recipients, we analyzed the course of renal function as a continuum over time using a series of mixed-effects regression analyses. This ap- proach allowed not only for the determination of which donor and recipient factors significantly influenced recipient Cr clearance after transplantation over prolonged periods of time, but also for the determination of the magnitude of their effects. Outcomes are depicted graphically in Figs 1 and 2 for univariate analyses and in Fig 4 for the final analysis using multiple explanatory variables. Most of the variability of observed recipient Cr clearance after transplantation is explained by this final analysis using these factors; this is shown in Fig 3 by the excellent correlation (r ϭ 0.96) between the observed recipient Cr clearance and the recipient Cr clearance predicted by this analysis.
As expected after rejection, Cr clearance fell significantly. Recipients remaining rejection-free had Cr clearance values approximately 10 mL/ min higher at all time points. This effect of rejection was superimposed on and could be separated from the influence of the other factors included in the analysis using multiple explanatory variables.
Donor hemodynamic instability 14 and mode of death (cardiovascular versus trauma) 2-3,5 have been associated with worse allograft outcome. In our analysis, we could not ascribe any significant influence to these factors as reflected by donor blood pressure (lowest donor systolic pressure), pressor administration, and occurrence of cardiac arrest on the initial and the subsequent course of recipient Cr clearance. When analyzed alone, the number of donor intensive care unit days appeared to have an impact on subsequent recipient Cr clearance. In the final analysis with inclusion of multiple explanatory variables, however, significance for this parameter was lost. Given the lack of standardization of documentation of blood pressure and pressor administration in the donor records reviewed, this finding may be methodologic.
When analyzed alone (Fig 2) and together with other factors, donor Cr clearance did influence subsequent recipient Cr clearance significantly (although modestly). This effect is most apparent after 2 to 3 years. No discernible impact was noted on recipient Cr clearance at 3 months. At 3-year follow-up, there is an approximately 10 mL/min difference of recipient Cr clearance between the first and third quartiles of donor Cr clearance. Karpinski et al, 10 using similar methodology to calculate donor GFR, also reported a modest influence of donor renal function on recipient GFR at 1 year. These investigators further showed that this effect was additive to 
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Time ϭ the number of years since the transplant. Recipient's sex ϭ 0 (1) for man (woman). Reject 1 ϭ 1 (0) after the first rejection (before the first rejection). Donor's age 1 ϭ 1 (0) if donor's age Յ 12 years (otherwise). Donor's age 2 ϭ 1 (0) if donor's age 12-20 years (otherwise). Donor's age 3 ϭ 1 (0) if donor's age 20-55 years (otherwise). Donor's age 4 ϭ 1 (0) if donor's age Ͼ55 years (otherwise).
and not explained fully by the impact of preexistent donor disease, as shown in implantation biopsy specimens.
It has been hypothesized that implantation of a small kidney into a large recipient has a negative impact on long-term allograft outcome as a result of the burden of an increased metabolic demand and the requirements of organ hypertrophy. Investigations of this hypothesis have yielded conflicting results. In a single-center experience, Vianello et al 15 reported no difference in allograft GFR, proteinuria, and survival over 4 years when comparing transplant recipients grouped by size disparity with their donors. Several studies of the UNOS database do support this proposed effect of body size disparity, however. A worse 1-year graft outcome was found when excessive height and weight differences occurred between donor and recipient (recipients of grafts from smaller donors faring worse). [16] [17] [18] Terasaki et al 3 and Chertow et al 2 found when analyzing this same registry that allografts transplanted into larger recipients had a lower 1-year survival and a shorter long-term half-life.
Conclusions drawn from our analyses do not confirm the effect of donor/recipient size disparity on renal function observed in these previous investigations. When evaluated as individual factors in the univariate analyses, small donor weight and small donor-to-recipient weight ratio favorably influence recipient Cr clearance at 1, 2, and 3 years of follow-up. Three-month Cr clearance does not appear to be affected by donor size. This discrepancy between our observations and those of earlier studies may be due to differences in the demographics of our donor population. As discussed subsequently, Cr clearance for recipients of allografts from pediatric donors in this study sample increased with time. Because approximately 20% of our donors compared with less than 6% in the UNOS registry were Ͻ7 years old, 19 this could bias our conclusions about the effect of donor/recipient size match when compared with studies comprising predominantly adult donors. When we repeated the analysis excluding these young donors, this advantageous impact of size was no longer significant.
Although in the final multiple variable analysis donor weight (as described earlier) did not appear to influence recipient Cr clearance, recipient gender, a possible surrogate marker for size, did retain significance. Cr clearance was 14.1 mL/min less in female recipients than in male recipients with female-to-female transplants having the lowest subsequent Cr clearance values.
In the analysis using multiple explanatory variables, only the presence of rejection, recipient gender, donor Cr clearance, and donor age retain significant independent influences on the subsequent course of recipient Cr clearance. As shown in Fig 4 , of all these factors, donor age appears to have the greatest impact on recipient Cr clearance at all time points. As expected, this analysis shows that recipients of kidneys from older donors had a lower Cr clearance when compared with recipients of kidneys from ideal adult donors aged 20 to55 years. [2] [3] [4] [5] [20] [21] [22] [23] [24] [25] [26] [27] [28] Our data are consistent with findings documented in analyses of the UNOS registry showing a progressive decline of recipient GFR with increasing donor age Ͼ20 years. 2, 26, 27 This effect of donor age could be due to disease demonstrable by biopsy at the time of transplantation. In a group of transplant recipients of organs from high-risk, predominantly older donors, Karpinski et al 10 correlated increased 1-year serum Cr with donor vascular pathology. In another single-center prospective study of recipients from donors of all ages, Pokorna et al 12 could not confirm this finding, however. These investigators observed using univariate analysis that the degree of donor glomerulosclerosis but not vascular disease influenced renal function at 1 and 2 years. In their final multivariate analysis, however, only donor age but not donor pathology retained a significant influence on GFR at 1 and 2 years.
Use of kidneys from very young donors (Ͻ5 years) remains controversial with programs reporting decreased, 2,3,23,24 normal, 29-32 and variable 33 graft function and survival. In this study, for recipients of kidneys from donors Ͻ12 years old (only 1 donor of the 19 in this group was Ͼ6 years old), Cr clearance increased gradually over the first 1.5 years to levels seen in adolescent donors. Although this increase in Cr clearance may predispose to hyperfiltration injury promoting the development of focal sclerosis, we have not noted this as yet. 31 We continue to follow-up these patients.
In conclusion, with the shortage of cadaveric donors, less than ideal donors will need to be used to curtail the ever-increasing waiting time for patients desiring transplantation. Our data show a tradeoff between use of less than ideal donors to alleviate time on the waiting list and subsequent renal allograft function over the first 3 years of follow-up. Independent of rejection, donor Cr clearance, donor age, and recipient gender in our analysis predictively influenced recipient Cr clearance. Of these factors, donor age appears from this analysis to have the greatest clinical impact. Data such as these may support development of selection and allocation strategies to optimize long-term outcome, such as the proposal to match older donors with older recipients.
